相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Impact of NRTIs on lipid levels among a large HIV-infected cohort initiating antiretroviral therapy in clinical care
Heidi M. Crane et al.
AIDS (2011)
The effect of tenofovir disoproxil fumarate on whole-body insulin sensitivity, lipids and adipokines in healthy volunteers
Paul A. Randell et al.
ANTIVIRAL THERAPY (2010)
Nevirapine Increases High-Density Lipoprotein Cholesterol Concentration by Stimulation of Apolipoprotein A-I Production
Remco Franssen et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2009)
Serum lipid profiles among patients initiating ritonavir-boosted atazanavir versus efavirenz-based regimens
Anuradha Ganesan et al.
AIDS Research and Therapy (2009)
HIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidity
Steven G. Deeks et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
British HIV Association guidelines for the treatment of HIV-1-infected adults with antiretroviral therapy 2008
B. G. Gazzard
HIV MEDICINE (2008)
European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of HIV-infected adults
N. Clumeck et al.
HIV MEDICINE (2008)
Metabolic issues associated with protease inhibitors
Graeme Moyle
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2007)
Class of antiretroviral drugs and the risk of myocardial infarction
Nina Friis-Moller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
A randomized comparative trial of tenofovir DF or abacavir as replacement for a thymidine analogue in persons with lipoatrophy
Graeme J. Moyle et al.
AIDS (2006)
Metabolic benefits 24 months after replacing a protease inhibitor with abacavir, efavirenz or nevirapine
C Fisac et al.
AIDS (2005)
Nevirapine and efavirenz elicit different changes in lipid profiles in antiretroviral-therapy-naive patients infected with HIV-1
F van Leth et al.
PLOS MEDICINE (2004)
Substitution of nevirapine, efavirenz, or abacavir for protease inhibitors in patients with human immunodeficiency virus infection
E Martinez et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Risk factors for coronary heart disease in patients treated for human immunodeficiency virus infection compared with the general population
M Savès et al.
CLINICAL INFECTIOUS DISEASES (2003)
Nevirapine-containing antiretroviral therapy in HIV-1 infected patients results in an anti-atherogenic lipid profile
M van der Valk et al.
AIDS (2001)